STAR rs104894086: Understanding Carrier Status

What each genotype means

What is rs104894086?

The variant rs104894086 is a specific genetic change located on chromosome 8 at position 38,146,068. In the context of human genetics, a single nucleotide polymorphism (SNP) like this represents a variation at a single position in the DNA sequence. This particular variant is found within the STAR gene, which provides instructions for creating the steroidogenic acute regulatory protein. Because this variant is associated with carrier status for a specific health condition, it is often studied in the context of clinical genetics and family planning. It is important to note that the presence of this variant does not automatically imply the presence of a disease, as the condition it is associated with follows an autosomal recessive inheritance pattern, meaning an individual typically needs to inherit two copies of a pathogenic variant to manifest the clinical symptoms.

The Role of the STAR Gene

The STAR gene is responsible for producing the steroidogenic acute regulatory protein, which plays a critical role in the synthesis of steroid hormones. This protein acts as a gatekeeper, facilitating the transport of cholesterol from the outer mitochondrial membrane to the inner mitochondrial membrane. This step is the rate-limiting and essential first stage in the production of all steroid hormones, including glucocorticoids, mineralocorticoids, and sex steroids. When the STAR protein is absent or non-functional, cholesterol cannot enter the mitochondria to be converted into pregnenolone, the precursor for these vital hormones. This disruption leads to a failure in steroidogenesis, which can have profound effects on adrenal function and sexual development. The gene is primarily expressed in steroidogenic tissues, such as the adrenal glands and gonads, highlighting its importance in endocrine health.

Research and Clinical Associations

Research has established that mutations in the STAR gene are the primary cause of lipoid congenital adrenal hyperplasia (LCAH). This condition is the most severe form of congenital adrenal hyperplasia, characterized by a profound inability to produce steroid hormones. Clinical evidence indicates that LCAH is an autosomal recessive disorder, meaning that individuals who are carriers (having one copy of a pathogenic variant) are typically unaffected. However, if two carriers have a child, there is a risk of passing on the condition. The evidence linking specific STAR variants to this condition is considered strong in clinical genetics, as the loss of STAR function directly correlates with the observed clinical phenotype of adrenal insufficiency and, in some cases, sex reversal in genetic males. Because this is a serious, potentially life-threatening condition if left untreated in infancy, genetic testing for this variant is often performed in clinical settings to assess carrier risk.

Understanding Your Results

If you have received information regarding your status for rs104894086, it is essential to understand that this is a carrier status marker. Being a carrier means you possess one copy of the variant, but you are generally not expected to show symptoms of the associated condition. This information is most relevant for family planning and reproductive health. It is important to emphasize that this article is for educational purposes and does not constitute medical advice or a diagnosis. Genetic testing results should always be interpreted by a qualified healthcare professional, such as a genetic counselor or a medical geneticist, who can provide context based on your personal and family medical history. If you have concerns about your carrier status or the implications for your family, please consult with a clinician to discuss appropriate testing and next steps.

Frequently asked questions

Sources & further reading